Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has provided an update.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the annual results for the year ending December 31, 2024, and consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial standing and potential shareholder returns, impacting its market position and stakeholder interests.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company incorporated in the People’s Republic of China, focusing on the development, manufacturing, and distribution of pharmaceutical products.
YTD Price Performance: 3.56%
Average Trading Volume: 3,056,813
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$8.82B
For detailed information about 1558 stock, go to TipRanks’ Stock Analysis page.